Publications by authors named "R Reshef"

Claim this Profile
A
A Conserved Landscape of Chemokine Receptor Co-expression Defines the Functional States of CD8+ T Cells in Melanoma.
Rodney Macedo, David W Harle, Kevin Hoffer-Hawlik, Ximi K Wang, Thomas McMahon-Skates, Ran Reshef

bioRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T-cells in multiple myeloma: the race to the start line.
Abdul-Hamid Bazarbachi, Divaya Bhutani, Michael Sang Hughes, Suzanne Lentzsch, Markus Mapara, Ran Reshef

Bone Marrow Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma.
Sattva S Neelapu, Julio C Chavez, Alison R Sehgal, Narendranath Epperla, Matthew L Ulrickson, Ran Reshef

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttransplant rituximab exposure and risk of PTLD in solid organ transplant recipients with EBV DNAemia.
Evelyn H Orlando, Patrick Gould, Brian Cuzzo, Maegan Ford, Yuxuan Chen, Ran Reshef

Blood Neoplasia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.
Yannis K Valtis, Chenyu Lin, David Nemirovsky, Sean M Devlin, Kai Rejeski, Ran Reshef

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis